Search Within

Nursing

  1. "EJC Supplements"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (3)
  2. Solid Tumor Oncology Division (2)
  3. Biostatistics Service (1)
  4. Center for Hematologic Malignancies (1)
  5. Epidemiology and Biostatistics (1)
  6. General Medicine Services (1)

More Groups

People
  1. Alan Houghton (1)
  2. Alexia Iasonos (1)
  3. Andrew Zelenetz (1)
  4. Barbara Macgregor-Cortelli (1)
  5. Barbara Pizzo (1)
  6. Catherine Hirst (1)

More People

Years
  1. 2007 (1)
  2. 2005 (1)
  3. 2003 (4)
Publications
  1. EJC Supplements (6)
Publishers
  1. Pergamon-Elsevier Science Ltd (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of sunitinib in patients (pts) with relapsed or refractory urothelial carcinoma (UC)
    Meeting Abstract

    Gallagher, D. J.; Milowsky, M. I.; Gerst, S. R.; Iasonos, A.; Boyle, M.; Riches, J.; Bajorin, D. B.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Rituximab maintenance therapy post autologous stem cell transplant (ASCT)
    Meeting Abstract

    Rice, R. D.; Moskowitz, C. H.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • KOS-862 (Epothilone D): Phase 1 dose escalating and pharmacokinetic (PK) study in patients (pts) with advanced malignancies
    Meeting Abstract

    Spriggs, D. R.; Dupont, J.; Pezzulli, S.; Larkin, J.; Cropp, G.; Zhou, Y.; Sherrill, M.; Johnson, R. Jr; Hannah, A. L.
    EJC Supplements (2003)

    Fulltext@MSK | Save
  • The epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib (TarcevaTM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: Interim results of a phase II trial
    Meeting Abstract

    Patel, J.; Miller, V.; Kris, M.; Shah, N.; Tyson, L.; Pizzo, B.; Zakowski, M.; Cespon, M.; Heelan, R.; Johnson, D.
    EJC Supplements (2003)

    Fulltext@MSK | Save
  • Phase II clinical experience with the novel proteasome inhibitor bortezomib (formerly PS-341) in patients with indolent and mantle cell lymphomas
    Meeting Abstract

    O'Connor, O. A.; Wright, J.; Moskowitz, C.; Straus, D.; Macgregor-Cortelli, B.; Muzzy, J.; Choi, P.; Schenkein, D.; Zelenetz, A. D.
    EJC Supplements (2003)

    Fulltext@MSK | Save
  • Phase I study of HSPPC-96 (Oncophage(R)) vaccine in patients with completely resected pancreatic adenocarcinoma
    Meeting Abstract

    Maki, R. G.; Lewis, J. J.; Janetzki, S.; Klimstra, D.; Desantis, D.; Hirst, C.; Houghton, A. N.; Srivastava, P. K.; Brennan, M. F.
    EJC Supplements (2003)

    Fulltext@MSK | Save